Home » Omicron variant: Modern, specific booster with higher dose – Healthcare

Omicron variant: Modern, specific booster with higher dose – Healthcare

by admin

Pharmaceutical company Moderna announces that it is testing a specific vaccine (mRNA-1273.529) against the Omicron variant in addition to its vaccine booster candidates. Against Omicron “we have three lines of defense advancing in parallel: a booster with a higher dose of mRNA-1273 (100 mg). Then, we are studying in the clinical phase two multi-valent booster candidates that anticipate mutations such as those emerged in Omicron. and data is expected for next week. We are also moving forward with a candidate specific booster against Omicron (mRNA-1273.529). ” This was stated by Stéphane Bancel, Moderna’s chief executive officer.

breaking latest news © Copyright ANSA


This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy